BB BIOTECH AG - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 173 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
BB BIOTECH AG ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$200,845,000
+51.3%
2,978,134
+3.5%
5.05%
+18.7%
Q4 2018$132,711,000
-21.7%
2,878,134
+30.9%
4.25%
-5.2%
Q3 2018$169,504,000
-8.4%
2,197,9310.0%4.48%
-16.1%
Q2 2018$185,132,000
-10.7%
2,197,931
-13.3%
5.34%
-6.7%
Q1 2018$207,333,000
+33.3%
2,535,253
-6.8%
5.73%
+30.9%
Q4 2017$155,502,000
-15.3%
2,719,998
-1.1%
4.38%
-13.8%
Q3 2017$183,562,000
+24.3%
2,749,998
-4.2%
5.08%
+12.6%
Q2 2017$147,637,000
-11.0%
2,869,528
+1.1%
4.51%
-16.8%
Q1 2017$165,828,000
+41.4%
2,839,528
+1.1%
5.42%
+24.9%
Q4 2016$117,242,000
-16.2%
2,809,528
+6.0%
4.34%
-11.7%
Q3 2016$139,948,000
+41.3%
2,649,528
+12.1%
4.92%
+25.9%
Q2 2016$99,011,000
+12.9%
2,363,321
+9.4%
3.91%
+12.1%
Q1 2016$87,693,000
-37.5%
2,159,9210.0%3.48%
-11.8%
Q4 2015$140,222,000
-5.9%
2,159,921
+2.4%
3.95%
-16.4%
Q3 2015$148,939,000
-32.7%
2,109,921
+6.0%
4.72%
-21.2%
Q2 2015$221,160,000
+26.8%
1,989,921
+7.6%
6.00%
+15.4%
Q1 2015$174,448,000
-16.5%
1,849,921
-0.8%
5.20%
-23.2%
Q4 2014$208,946,000
+80.2%
1,864,921
-1.4%
6.77%
+43.5%
Q3 2014$115,983,000
+400.3%
1,890,521
+273.6%
4.72%
+327.9%
Q2 2014$23,185,000506,0001.10%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 2,661,605$61,137,0671.46%
Bellevue Group AG 4,013,500$92,190,0951.34%
Eagle Health Investments LP 267,630$6,147,4611.20%
ARMISTICE CAPITAL, LLC 3,460,000$79,476,2001.14%
Integral Health Asset Management, LLC 213,000$4,892,6100.99%
SUVRETTA CAPITAL MANAGEMENT, LLC 454,000$10,428,3800.44%
ArrowMark Colorado Holdings LLC 1,557,705$35,780,4840.41%
FARALLON CAPITAL MANAGEMENT LLC 2,092,829$48,072,2820.27%
Virtus ETF Advisers LLC 9,932$228,1380.13%
JACOBS LEVY EQUITY MANAGEMENT, INC 614,533$14,115,8230.09%
View complete list of AGIOS PHARMACEUTICALS INC shareholders